542 related articles for article (PubMed ID: 33304284)
21. Putative mechanism of neurological damage in COVID-19 infection.
Bandala C; Cortes-Altamirano JL; Reyes-Long S; Lara-Padilla E; Ilizaliturri-Flores I; Alfaro-Rodríguez A
Acta Neurobiol Exp (Wars); 2021; 81(1):69-79. PubMed ID: 33949163
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19.
Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A
Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500
[TBL] [Abstract][Full Text] [Related]
23. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries.
Román GC; Spencer PS; Reis J; Buguet A; Faris MEA; Katrak SM; Láinez M; Medina MT; Meshram C; Mizusawa H; Öztürk S; Wasay M;
J Neurol Sci; 2020 Jul; 414():116884. PubMed ID: 32464367
[TBL] [Abstract][Full Text] [Related]
24. Neurological manifestations and comorbidity associated with COVID-19: an overview.
Kumar M; Thakur AK
Neurol Sci; 2020 Dec; 41(12):3409-3418. PubMed ID: 33052573
[TBL] [Abstract][Full Text] [Related]
25. The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations.
Maranduca MA; Vamesu CG; Tanase DM; Clim A; Drochioi IC; Pinzariu AC; Filip N; Dima N; Tudorancea I; Serban DN; Serban IL
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556919
[TBL] [Abstract][Full Text] [Related]
26. What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?
Nicolau LAD; Magalhães PJC; Vale ML
Med Hypotheses; 2020 Oct; 143():109886. PubMed ID: 32504925
[TBL] [Abstract][Full Text] [Related]
27. Neurological Sequelae of COVID-19.
Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
[TBL] [Abstract][Full Text] [Related]
28. ACE2, Much More Than Just a Receptor for SARS-COV-2.
Samavati L; Uhal BD
Front Cell Infect Microbiol; 2020; 10():317. PubMed ID: 32582574
[TBL] [Abstract][Full Text] [Related]
29. Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2.
Elrashdy F; Redwan EM; Uversky VN
Infect Genet Evol; 2020 Nov; 85():104510. PubMed ID: 32853823
[TBL] [Abstract][Full Text] [Related]
30. Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases.
Tanzadehpanah H; Lotfian E; Avan A; Saki S; Nobari S; Mahmoodian R; Sheykhhasan M; Froutagh MHS; Ghotbani F; Jamshidi R; Mahaki H
Biomed Pharmacother; 2023 Oct; 166():115321. PubMed ID: 37597321
[TBL] [Abstract][Full Text] [Related]
31. Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19.
Rieder M; Wirth L; Pollmeier L; Jeserich M; Goller I; Baldus N; Schmid B; Busch HJ; Hofmann M; Kern W; Bode C; Duerschmied D; Lother A
Am J Hypertens; 2021 Apr; 34(3):278-281. PubMed ID: 33043967
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the angiotensin-converting enzyme 2 (ACE2), the main receptor for the SARS-CoV-2 virus.
Jami G; Ataee M; Esmaeili V; Chamani S; Rezaei A; Naghizadeh A
Am J Clin Exp Immunol; 2023; 12(3):24-44. PubMed ID: 37457503
[TBL] [Abstract][Full Text] [Related]
33. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
34. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
[TBL] [Abstract][Full Text] [Related]
35. ACE2 as a Therapeutic Target for COVID-19; its Role in Infectious Processes and Regulation by Modulators of the RAAS System.
Michaud V; Deodhar M; Arwood M; Al Rihani SB; Dow P; Turgeon J
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32635289
[TBL] [Abstract][Full Text] [Related]
36. The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019.
Coto E; Avanzas P; Gómez J
Eur Cardiol; 2021 Feb; 16():e07. PubMed ID: 33737961
[TBL] [Abstract][Full Text] [Related]
37. The Impact of
Rodrigues R; Costa de Oliveira S
Microorganisms; 2021 Aug; 9(8):. PubMed ID: 34442770
[TBL] [Abstract][Full Text] [Related]
38. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
Murta V; Villarreal A; Ramos AJ
ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
Datta PK; Liu F; Fischer T; Rappaport J; Qin X
Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
[TBL] [Abstract][Full Text] [Related]
40. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection.
Beyerstedt S; Casaro EB; Rangel ÉB
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):905-919. PubMed ID: 33389262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]